Aktis Oncology

Exciting developments at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (#ENA2024)!      Today, Mike Sathekge, MD, Head of Nuclear Medicine Department, University of Pretoria, and Steve Biko Academic Hospital, and President and CEO, Nuclear Medicine Research Infrastructure (NuMeRI), is delivering an oral presentation supporting AKY-1189’s potential to treat patients with various Nectin-4 expressing cancers.     Learn more about the potential of Aktis Oncology’s AKY-1189 in targeting Nectin-4 expressing cancers: https://lnkd.in/eRVsvH6E     #AktisOncology #RadioPharma 

Aktis Oncology is looking forward to attending the 36th Annual #ENA2024 (EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics) in Barcelona this week!      Aktis will be presenting three abstracts, including an oral presentation, around our potential first-in-class, Nectin-4 targeting miniprotein radiopharmaceutical, AKY-1189.   To learn more about the symposium and our data presentations, visit https://lnkd.in/eb6tKDZE.     #AktisOncology 

Aktis Oncology is looking forward to attending the 36th Annual #ENA2024 (EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics) in Barcelona this week!      Aktis will be presenting three abstracts, including an oral presentation, around our potential first-in-class, Nectin-4 targeting miniprotein radiopharmaceutical, AKY-1189.   To learn more about the symposium and our data presentations, visit https://lnkd.in/eb6tKDZE.     #AktisOncology 

Aktis Oncology is proud to announce the addition of 5 exceptional professionals to our team. Join us in extending a warm welcome to our newest colleagues! 👋Courtney Utsey, SPHR Courtney Utsey joins as a Director, Total Rewards & People Operations, bringing professional expertise in scaling and maximizing processes and programs that help people succeed and grow in the workplace. Outside of work, you can find Courtney traveling or spending time with her cat.   👋 Naomi Biok  Naomi Biok joins us as a Principal Scientist in the Chemistry group. Naomi’s experience in peptide design, synthesis, and screening will be leveraged for lead optimization. An outdoor enthusiast and self-proclaimed nerd, Naomi enjoys all things science fiction and spending time in the wilderness with her husband and dog. 👋 Amy Smith Gibbons Amy Smith Gibbons joins us as a Senior Director, Alliance & Program Management, bringing over a decade of drug development experience. Amy has a passion for oncology drug development and bringing hope to patients. Outside of work, you will find Amy spending time with her family, spoiling her dog, and attempting to broaden her amateur gardening skills.   👋 Nate Demars Nate Demars joins us as Executive Director, Head of Clinical Operations. Nate enjoys working in a cross-functional, fast-paced environment with the goal of bringing innovative therapies to cancer patients. Originally from Connecticut, Nate is an avid UConn Huskies fan and enjoys watching his kids play sports, golfing, and traveling.   👋 Katharina Bormann, PharmD Katharina Borman joins us as a Scientist, Radiopharmaceutical Development in the Chemistry, Manufacturing and Controls (CMC) team. Katharina is a perpetual learner of emerging pharmaceuticals, technologies, and treatment approaches. Outside of work, you can find Katharina using her cargo bike to commute to work daily, enjoying a cup of coffee, or traveling to experience new places, cultures, and languages. The wealth of experience, passion, and unique perspectives these individuals bring will help us continue to discover and deliver transformative therapies to oncology patients.   Looking to join a company positioned to deliver real breakthroughs in cancer care? Visit https://lnkd.in/erWzsAff #NewHires #BioPharma #CancerResearch #AktisOncology #WereHiring 

This National Hispanic Heritage Month, we honor the remarkable impact of Hispanic scientists in oncology and beyond. From Dr. Baruj Benacerraf's Nobel Prize-winning immunology research to Dr. Antonia Novello's groundbreaking role as U.S. Surgeon General, Hispanic innovators have long been at the forefront of medical advancement.    At Aktis Oncology, these achievements inspire our work and reinforce our commitment to fostering diversity in scientific innovation. We celebrate the rich heritage and invaluable contributions of Hispanic researchers shaping the future of science and medicine.    #HispanicHeritageMonth #DiversityInSTEM #CancerResearch 

Thank you Nasdaq for your recognition of our Series B raise of $175M! This milestone fuels our mission to transform cancer care through innovative radiopharmaceuticals.    A huge thank you to our investors, team, and partners for their continued support and belief in our vision. We're excited to advance our proprietary pipeline and make a meaningful difference for cancer patients.    Learn more about our Series B and future plans: https://lnkd.in/eYANNP84    #BiotechInnovation #CancerResearch #Radiopharmaceuticals

We are pleased to share that Aktis closed a $175 million Series B financing. The financing was led by RA Capital Management, and co-led by RTW Investments, Janus Henderson Investors, and was joined by a select syndicate of additional new investors, including funds and accounts advised by T.Rowe Price Associates, Inc., Avidity Partners, and an undisclosed life sciences-focused investment fund. Proceeds raised will be used to further advance our radiopharmaceuticals pipeline, including our first-in-class Nectin-4-targeted miniprotein radioconjugate. To read more, visit https://lnkd.in/eYANNP84

Shiver me timbers, we recently celebrated International Talk Like a Pirate Day! 🏴☠️   At Aktis Oncology, we are on a tireless quest to conquer cancer, without forgetting to have a bit of fun. Our crew could be found donning eye patches and pirate hats to celebrate this most ridiculous of holidays! We are firm believers that a happy crew makes for smooth sailing in the choppy waters of biotechnology.   #TalkLikeAPirateDay #AktisOncology #CompanyCulture #JoinUs

Today marks World Cancer Research Day and this year’s focus raises awareness of diversity and inclusivity in cancer research. Diversity and inclusivity in research are vital for preventing more cancers, improving survival rates, and enhancing the quality of life for all patients. At Aktis Oncology, we're proud to support this crucial initiative. Join us in recognizing the importance of diverse representation in cancer research. Together, we make strides towards more effective treatments and better outcomes for everyone affected by cancer. #WorldCancerResearchDay #CancerResearch #Diversity #AktisOncology

Aktis Oncology proudly announces the addition of four outstanding professionals to our growing team.   👋 Julius Y-H Huang, PhD, DABT Julius Huang joins as a Senior Director, Clinical Scientist. With her data analysis and problem-solving skills, Julius will work on all aspects of clinical development with a focus on early-phase trials. Outside of work, Julius enjoys reading, hiking, and visiting national parks.   👋 Tatyana Sanders Tatyana Sanders joins as our Administrative Assistant in Research Triangle Park. She brings her stellar administrative experience in finance to the biotechnical industry. As she has recently relocated to Raliegh, NC from New York, she’s very excited about exploring the city and immersing herself in the culture.   👋 Julie E. Pickett, PhD Julie Pickett joins us as a Scientist in the Radiobiology group. Julie’s scientific background in synthetic organic chemistry, small animal PET, and GPCR functional assays has her primed for understanding and contributing to Aktis’ pharmacological needs. While not in the lab, she enjoys spending time with friends, family, and her cats, volunteering with Independent Animal Rescue, and practicing aerial silks and hand balancing.   👋 Marta Sanchez-Martin, PhD Marta joins us as a Senior Director, Translational Science. She brings translational scientific expertise to support advancement of Aktis’ assets into the clinic by building biomarker strategies and leading reverse translation efforts. She loves travelling the world with family, reading, listening to music, and recently picked up running and bouldering. These individuals bring a wealth of experience, passion, and unique perspectives that further enhance our amazing team. We extend a warm welcome and invite you to join us in celebrating our newest colleagues. To learn more about our open positions, visit: https://lnkd.in/erWzsAff   #NewHires #BioPharma #CancerResearch #AktisOncology #WereHiring